Cress Pharmaceuticals Private Limited
About Cress Pharmaceuticals Private Limited
Data last updated:
Cress Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 06 May 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51909TG2019PTC132536. Its GSTIN is 37AAICC1650K1ZK (Andhra Pradesh).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Chandra Sekhar Bodavula and Ravi Kumar Ravula.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.54 Lakh, a decline of 45% compared to the previous year. For the same year it recorded a net loss of ₹69,602 (net margin -19.7%) and EBITDA of -₹66,350 (EBITDA margin -18.7%). Revenue has declined at a compounded annual rate (CAGR) of 37% over three years.
Company details
Contact details
Cress Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressD.No.8 – 43/3/9 Flat No. 204 V. R. Lakshmi Paradise Srinivasa Colony, Uppal, Hyderabad, Telangana, India – 500039
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Cress Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cress Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Cress Pharmaceuticals Private Limited, buy the company report.
Financials of Cress Pharmaceuticals Private Limited
FY 2024 filings availableCress Pharmaceuticals Private Limited reported revenue of ₹3.54 Lakh (down 45% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 37% over three years, including a 45% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹66,350 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹69,602 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -18.7% | ||||
| Net Profit Margin | -19.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cress Pharmaceuticals Private Limited, buy the company report.
Board of directors of Cress Pharmaceuticals Private Limited
Cress Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandra Sekhar Bodavula | Director | 06 May 2019 | 7 Years 5 Months | Current |
| Ravi Kumar Ravula | Director | 06 May 2019 | 7 Years 5 Months | Current |
| Sudheer Peravali | Director | 14 Oct 2019 | 7 Years 0 Months | Current |
Peer comparison
Cress Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Saipen Pharmaceuticals Private Limited | ₹3.57 Lakh (FY 2019) | 84.0% | Patna, Bihar, India | |||
| Shubhecha Pharmaceuticals Private Limited | ₹3.54 Lakh (FY 2023) | 1084.0% | Lucknow, Uttar Pradesh, India | |||
| Medanta Pharmaceuticals Private Limited | ₹3.54 Lakh (FY 2022) | -58.0% | Ahmedabad, Gujarat, India | |||
| Cress Pharmaceuticals Private Limitedthis company | ₹3.54 Lakh (FY 2024) | -₹69,602 | -19.7% | -45.0% | Hyderabad, Telangana, India | |
| Bio Oasis Pharmaceuticals Private Limited | ₹3.54 Lakh (FY 2025) | -18.0% | Khanpur, Deoli, Delhi, India | |||
| Litmus Pharmaceuticals Private Limited | ₹3.51 Lakh (FY 2024) | -83.0% | Avadhpur, Haryana, India |
To see the full peer comparison of Cress Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cress Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cress Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cress Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAICC1650K1ZK | Andhra Pradesh | Active | 20 Jun 2019 |
To see the full GST registrations and return filing status of Cress Pharmaceuticals Private Limited, buy the company report.
Recent activity
Cress Pharmaceuticals Private Limited has 4 board changes on record since 2019: 3 appointments and 1 cessation. The latest: Eesub Shaik ceased to be Director on 09 Dec 2019.
Frequently asked questions
Cress Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in specialty, within the trading industry. It was incorporated on 06 May 2019 (7+ years old) and is registered under CIN U51909TG2019PTC132536.
Cress Pharmaceuticals has 3 current directors:
- Chandra Sekhar Bodavula - Director
- Ravi Kumar Ravula - Director
- Sudheer Peravali - Director
The latest financial statements of Cress Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Cress Pharmaceuticals is 37AAICC1650K1ZK, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Cress Pharmaceuticals is U51909TG2019PTC132536. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cress Pharmaceuticals was incorporated on 06 May 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Cress Pharmaceuticals by revenue are Saipen Pharmaceuticals Private Limited, Shubhecha Pharmaceuticals Private Limited, Medanta Pharmaceuticals Private Limited, Bio Oasis Pharmaceuticals Private Limited, Litmus Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Eesub Shaik ceased to be Director on 09 Dec 2019. Sudheer Peravali was appointed as Director on 14 Oct 2019. Chandra Sekhar Bodavula was appointed as Director on 06 May 2019. Cress Pharmaceuticals has 4 board changes on record in total.
The registered office of Cress Pharmaceuticals is at D.No.8 – 4339 Flat No. 204 V. R. Lakshmi Paradise Srinivasa Colony, Uppal, Hyderabad, Telangana, India – 500039.
Cress Pharmaceuticals operates in the trading industry, in the specialty segment.
Cress Pharmaceuticals can be reached at its registered office: D.No.8 – 4339 Flat No. 204 V. R. Lakshmi Paradise Srinivasa Colony, Uppal, Hyderabad, Telangana, India – 500039.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
